methenamine mandelate 500 MG / sodium phosphate, monobasic 500 MG Oral Tablet [Uroqid-Acid No.2]
RxNorm concept 829031, branded drug (sbd). Prescribable name: Uroqid-Acid No.2 500 MG / 500 MG Oral Tablet.
- RxCUI
- 829031
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/829031 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Uroqid-Acid No.2 (methenamine mandelate 500 MG / sodium phosphate, monobasic 500 MG) Oral Tablet; Uroqid-Acid No.2 Oral Tablet
Related concepts
- methenamine mandelate 500 MG (SCDC, consists of)
- sodium phosphate, monobasic 500 MG (SCDC, consists of)
- methenamine mandelate 500 MG / sodium phosphate, monobasic 500 MG [Uroqid-Acid No.2] (SBDC, consists of)
- Oral Tablet (DF, has dose form)
- Uroqid-Acid No.2 (BN, has ingredient)
- methenamine mandelate 500 MG / sodium phosphate, monobasic 500 MG Oral Tablet (SCD, tradename of)
Linked data
NDCs
- 00486111401
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 829031 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/829031 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 829031. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.